Dr. John K. Midturi, DO

Dr. Midturi practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Midturi's NPI, 1932169455, was assigned on March 27, 2006. Dr. Midturi graduated from Texas College of Osteopathic Medicine in 1999. Dr. Midturi holds Texas license L4061.

Dr. Midturi's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Midturi's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Midturi is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Midturi practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Midturi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Midturi is board certified in infectious disease by the American Board of Internal Medicine. Dr. Midturi is licensed in Texas.

Dmand AI lists hiv/aids, immune deficiency disease, joint or bone infection and pneumonia among the conditions Dr. Midturi treats.

CMS data shows 271 Medicare services from Dr. Midturi across 4 procedure codes in 2024, for 132 Medicare patients. Medicare paid $23,856 for them.

CMS counts 132 Medicare patients who saw Dr. Midturi in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Midturi's median patient age at 68, with 43% women.

In 2024, Dr. Midturi wrote 660 Medicare Part D claims for 89 patients. 46% of them were for generic drugs. CMS names the drug for 430 of them, across 19 drugs with 11 or more claims each, at $1,213,897 in total drug cost. In 2023, CMS named 446 claims across 19 drugs.

Dr. Midturi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Midturi as offering telehealth. CMS counts 33 procedures of removal of tissue by Dr. Midturi, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Midturi, published from 2004 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, COVID-19 and Hand Hygiene. Dr. Midturi's most frequent co-authors are Alejandro C. Arroliga, MD, Ryan L. Beaver, DO and Lizbeth Cahuayme-Zuniga, MD.

CMS Open Payments shows 62 general payments to Dr. Midturi from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 48% of the total. Abbvie Inc. paid the most, $1,418.

Dr. Midturi graduated from Texas College of Osteopathic Medicine in 1999.

Dr. Midturi is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.